IGC-504

N/A

Report date: 2023/09/18 14:39:50
NME

Base Information

Drug NameIGC-504
Drug Alias NameIGC-504
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid receptor modulators
TargetsCannabinoid receptor
Therapy Area/IndicationsDiabulimia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIGC Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesIGC Pharma Inc
Inactive CompaniesN/A
Active IndicationsDiabulimia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A